CAS: 1374248-81-3
Atogepant
CAS:1374248-81-3
Atogepant (MK-8031) is an orally available, selective and potent calcitonin gene-related peptide receptor (CGRP) antagonist …
Formula:
C29H23F6N5O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
603.52
Ref: TM-T26682
1mg | 159.00 € | ||
5mg | 383.00 € | ||
10mg | 568.00 € | ||
25mg | 888.00 € | ||
50mg | 1,205.00 € | ||
100mg | 1,621.00 € | ||
500mg | 3,295.00 € |
Estimated delivery in United States, on Friday 10 Jan 2025
Ref: 4Z-A-389002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-A-389001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-A-389011
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Atogepant
CAS:1374248-81-3
Atogepant is a drug for the treatment of migraine that belongs to the group of …
Formula:
C29H23F6N5O3
Purity:
Min. 95%
Molecular weight:
603.52 g/mol
Ref: 3D-FA165700
1mg | 1,160.00 € | ||
2mg | 2,087.00 € | ||
5mg | 2,898.00 € | ||
10mg | 4,637.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025